Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0140-6736(73)90997-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
In Reply to Gad Et Al "Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay".
Clin Endocrinol (Oxf)
January 2025
Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Clinical Impact of New Reference Intervals for the Roche Prolactin II Immunoassay.
Clin Endocrinol (Oxf)
January 2025
Department of Endocrinology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
Kangaroo Mother Care Induced Serum Oxytocin Facilitates Prolactin and IL-10 Among Emergency Cesarean Mothers [Letter].
J Multidiscip Healthc
July 2024
Midwifery Department, Poltekkes Kemenkes, Banjarmasin, Indonesia.
Reply to the Letter to the Editor on "Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children".
Horm Metab Res
June 2024
Paediatric Department, Shaoxing Women and Children's Hospital, Shaoxing, China.
Dear Editor,The authors thank the writers 1 of the letter for reviewing and assessing our article 2, "Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children". Overall, we agree that possible selection bias must be considered. However, in clinical studies, we found that hyperprolactinemia is mainly caused by pathological and idiopathic hyperprolactinemia.
View Article and Find Full Text PDFRe: Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children.
Horm Metab Res
June 2024
Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, General Hospital Nuremberg and Paracelsus Medical University, Nuremberg, Germany.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!